Compare TCBS & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TCBS | NTRB |
|---|---|---|
| Founded | 1934 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Banks | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.7M | 57.0M |
| IPO Year | N/A | N/A |
| Metric | TCBS | NTRB |
|---|---|---|
| Price | $16.68 | $4.24 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $13.00 |
| AVG Volume (30 Days) | 3.1K | ★ 65.8K |
| Earning Date | 11-07-2025 | 12-11-2025 |
| Dividend Yield | ★ 1.17% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.87 | N/A |
| Revenue | ★ $15,268,000.00 | $2,278,321.00 |
| Revenue This Year | N/A | $30.17 |
| Revenue Next Year | N/A | $3,394.36 |
| P/E Ratio | $19.78 | ★ N/A |
| Revenue Growth | ★ 54.88 | 12.69 |
| 52 Week Low | $15.00 | $3.90 |
| 52 Week High | $20.00 | $11.78 |
| Indicator | TCBS | NTRB |
|---|---|---|
| Relative Strength Index (RSI) | 47.43 | 39.08 |
| Support Level | $16.85 | $4.33 |
| Resistance Level | $18.53 | $4.63 |
| Average True Range (ATR) | 0.82 | 0.37 |
| MACD | -0.07 | -0.00 |
| Stochastic Oscillator | 16.30 | 1.81 |
Texas Community Bancshares Inc is a holding company. The company's business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank of Dallas, in residential real estate loans and commercial real estate loans and, to a lesser extent, commercial loans, construction and land loans, and consumer and other loans. Its portfolio segments are real estate, agriculture, commercial, consumer and other.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.